Literature DB >> 10125323

Pharmacoeconomic series: Part I. Pharmacoeconomics and the evaluation of drugs and services.

W F McGhan1.   

Abstract

The field of pharmacoeconomics is of growing interest to everyone from government policy makers to medical staff and administrators at hospitals and other managed care settings. This article reviews basic terminology and methodologic issues related to using pharmacoeconomics to evaluate drugs and services. Economic evaluation tools such as cost-benefit analysis, cost-effectiveness analysis, cost-utility analysis, and cost-minimization analysis are described. The challenge for all clinicians is to use these economic evaluation tools to optimize the benefit-to-cost ratio and resultant positive outcome of programs, services, treatments, or other interventions for the patient, the institution, and society.

Entities:  

Mesh:

Year:  1993        PMID: 10125323

Source DB:  PubMed          Journal:  Hosp Formul        ISSN: 0098-6909


  3 in total

Review 1.  Expanding the role of pharmacists in pharmacoeconomics: why and how?

Authors:  L A Sanchez
Journal:  Pharmacoeconomics       Date:  1994-05       Impact factor: 4.981

2.  Implementing pharmacoeconomic outcomes management.

Authors:  W F McGhan; B A Briesacher
Journal:  Pharmacoeconomics       Date:  1994-11       Impact factor: 4.981

3.  A pharmacoeconomic evaluation of the effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes in Spain.

Authors:  Juan Antonio Gómez-Gerique; Roman Casciano; Lee Stern; Javier Rejas
Journal:  Eur J Health Econ       Date:  2004-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.